metapsy-project/data-depression-psiloctr: Version 25.1.2
Zenodo (CERN European Organization for Nuclear Research)Β β November 20, 2025
Source: OpenAlex
Summary
The potential of psilocybin-assisted therapies for depression is being rigorously analyzed through a new **domain** of **mathematical analysis**. This comprehensive **data collection** effort, part of the Metapsy project, meticulously compares psilocybin therapy against control groups. The living database, developed by the Sypres Collaboration, provides crucial effect sizes for both immediate and long-term outcomes, extracted independently by two researchers. Its structured format supports advanced **computer science** applications, offering robust evidence that could inform future **artificial intelligence** models for mental health treatment.
Abstract
The data-depression-psiloctr dataset π The data-depression-psiloctr dataset is a meta-analytic research domain (MARD) on psilocybin-assisted therapies for adults with depressive symptoms. This MARD is part of the Metapsy project. The date of the last search update is provided here. This dataset includes psilocybin-assisted therapy vs. control ('psy vs ctr') comparisons. Effect sizes are provided for outcomes at post-test and long-term follow-ups, if available. This living database has been developed by the Sypres (Synthesis of Psychedelic Research Studies) Collaboration. Further information on Sypres and its underlying methodology can be found in this published article. The dataset follows the Metapsy data standard. All included information has been independently extracted two researchers. Risk of bias ratings were conducted using the Cochrane Collaboration Risk of Bias Tool (Version 2).